August 7, 2018 -- Wolf Point Growth Partners ("WPGP") announced today a strategic partnership investment in Caravel Autism Health by Frazier Healthcare Partners (www.frazierhealthcare.com). Graue Mill Partners, LLC, as a lead WPGP investor, is extremely pleased with the opportunity for Caravel to combine with a larger, more resourceful capital partner in Frazier Healthcare. "Caravel has done a spectacular job in putting in place the operating sophistication and accelerated growth model which today has positioned the Company as the high quality provider in the autism health space, and which now has been able to attract an ideal partner for even more accelerated growth going forward with Frazier Healthcare," commented GMP Founder and Caravel Board Member, Robert S. Whitelaw. "GMP looks forward to its ongoing participation with Caravel, as it continues to expand both geographically and as a broader autism health services provider," he added.
"Frazier Healthcare Partners has made a strategic investment in Caravel Autism Health to back the team as they expand best-in-class autism treatment and outcomes to more clients and their families," said Dr. Nathan Every, M.D., Frazier General Partner. "We have evaluated many investment opportunities in the autism treatment sector, and we believe Caravel represents a truly unique combination of clinical excellence and growth-oriented leadership."